UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

August 11, 2013

 


 

MULTICELL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-10221 52-1412493
(State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer
Identification No.)

 

68 Cumberland Street, Suite 301

Woonsocket, RI 02895

(Address of principal executive offices, including zip code)

 

(401) 762-0045

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 8.01 Other Events

 

On August 11, 2013, Scott Lukeman, a director of MultiCell Technologies, Inc. (the “Company”) died from a heart attack. Pursuant to the Company’s Bylaws, the remaining directors may fill the vacancy on the Company’s Board of Directors. As of the date of filing of this Current Report on Form 8-K, the vacancy had not yet been filled.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MULTICELL TECHNOLOGIES, INC.
     
     
  By:   /s/ W. Gerald Newmin  
   

W. Gerald Newmin

Chief Executive Officer, Chief Financial Officer

 

Date: August 14, 2013